In the latest report from Emergen Research, the market research report discusses the global Direct-to-Consumer Genetic Testing market in depth, and each of the major market segments is examined in depth. In addition to market information, the report provides industry statistics, regional market revenue shares, gross profits, production & distribution costs, and product portfolios related to the global Direct-to-Consumer Genetic Testing market.
There are also a number of factors influencing industry revenue growth identified in the report, including drivers, opportunities, trends, restraints, challenges, demand and supply ratios, production and consumption patterns, stringent regulatory frameworks, as well as a multitude of other micro- and macro-economic factors.
The global Direct-to-Consumer Genetic Testing Market is forecasted to reach USD 3.33 Billion by 2027, according to a new report by Emergen Research. Increasing genetic disease incidence would fuel competition for direct-to-consumer genetic testing and accelerate market development across the expected timeframe. Increasing cases of hereditary disorders such as breast cancer, achondroplasia, colorectal cancer and other diseases have increased the need for cost-effective and reliable avenues of genetic testing in the healthcare industry. For reference, according to the World Cancer Research Fund (WCRF), more than 2 million new cancer cases were reported globally in 2018. Breast cancer is now considered to be the second most prevalent disease. The introduction of a superior standard and innovative direct-to-consumer genetic testing has significantly lowered mortality levels of people with cancer by maintaining diligence surveillance data even before the onset of the disease. The preceding conditions would, therefore, accelerate the demand for direct-to-consumer genetic testing to reverse the timetable for the prediction.
Get a sample of the report @ https://www.emergenresearch.com/request-sample/20
Market Dynamics:
The report explains the scope of various commercial possibilities in the global Direct-to-Consumer Genetic Testing market over the upcoming years. The estimated revenue build-up over the forecast years has been included in the report. The report analyzes the key market segments and sub-segments and provides deep insights into the market to assist readers with the formulation of lucrative strategies for business expansion.
Competitive Landscape:
Furthermore, the report includes an in-depth analysis of the competitive landscape. The segment covers a comprehensive overview of the company profiles along with product profiles, production capacities, products/services, pricing analysis, profit margins, and manufacturing process developments.
The report also covers strategic business measures undertaken by the companies to gain substantial market share.
Key Companies Profiled in the Report:
23andMe, Full Genome Corporation, Color Genomics, Genesis Healthcare, Helix OpCo LLC, FamilyTreeDNA, MyHeritage, Identigene, Pathway genomics, and Living DNA, among others
Target Audience of the Global Direct-to-Consumer Genetic Testing Market Report:
- Key Market Players
- Investors
- Venture capitalists
- Small- and medium-sized and large enterprises
To know more about the report, visit @ https://www.emergenresearch.com/industry-report/direct-to-consumer-genetic-testing-market
Direct-to-Consumer Genetic Testing Market Segmentation:
-
Test Type Outlook (Volume, Kilo Tons; 2017-2027) (Revenue, USD Billion; 2017-2027)
- Carrier Testing
- Predictive Testing
- Ancestry & Relationship Testing
- Nutrigenomics Testing
- Others
-
Distribution Channel Outlook (Volume, Kilotons; 2017-2027, Revenue, USD Billion; 2017-2027)
- Online Platforms
- Over-the-Counter
-
Application Outlook (Volume, Kilo Tons; 2017-2027) (Revenue, USD Billion; 2017-2027)
- Targeted Analysis
- Single Nucleotide Polymorphism Chips (SNP)
- Whole Genome Sequencing (WGS)
Regional Segmentation;
North America (U.S., Canada)
Europe (U.K., Italy, Germany, France, Rest of EU)
Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
Latin America (Chile, Brazil, Argentina, Rest of Latin America)
Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)
Request customization of the report @ https://www.emergenresearch.com/request-for-customization/20
Related Reports
Diabetes Care Devices Market
https://www.emergenresearch.com/industry-report/diabetes-care-devices-market
Patient Lateral Transfer Market
https://www.emergenresearch.com/industry-report/patient-lateral-transfer-market
Angiographic Catheters Market
https://www.emergenresearch.com/industry-report/angiographic-catheters-market
Nuclear Medicine Market
https://www.emergenresearch.com/industry-report/nuclear-medicine-market
Medical Equipment Maintenance Market
https://www.emergenresearch.com/industry-report/medical-equipment-maintenance-market
Cardiac Mapping Market
https://www.emergenresearch.com/industry-report/cardiac-mapping-market
About Us:
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
Eric Lee
Corporate Sales Specialist
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Visit for More Insights: https://www.emergenresearch.com/insights
